
Eric Olson
Examiner (ID: 2127)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 1713 |
| Issued Applications | 963 |
| Pending Applications | 131 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6930856
[patent_doc_number] => 20050281891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Testosterone stimulant'
[patent_app_type] => utility
[patent_app_number] => 11/145545
[patent_app_country] => US
[patent_app_date] => 2005-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7269
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20050281891.pdf
[firstpage_image] =>[orig_patent_app_number] => 11145545
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/145545 | Testosterone stimulant | Jun 1, 2005 | Abandoned |
Array
(
[id] => 7251727
[patent_doc_number] => 20050272926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Non-crystalline cellulose and production thereof'
[patent_app_type] => utility
[patent_app_number] => 11/142936
[patent_app_country] => US
[patent_app_date] => 2005-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7831
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272926.pdf
[firstpage_image] =>[orig_patent_app_number] => 11142936
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/142936 | Non-crystalline cellulose and production thereof | Jun 1, 2005 | Abandoned |
Array
(
[id] => 7966367
[patent_doc_number] => 07939530
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-10
[patent_title] => 'Treatment of lymphoma using 10-propargyl-10-deazaaminopterin and gemcitabine'
[patent_app_type] => utility
[patent_app_number] => 11/568254
[patent_app_country] => US
[patent_app_date] => 2005-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6912
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/939/07939530.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568254
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568254 | Treatment of lymphoma using 10-propargyl-10-deazaaminopterin and gemcitabine | May 30, 2005 | Issued |
Array
(
[id] => 5821066
[patent_doc_number] => 20060025379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Small molecule stimulators of neuronal growth'
[patent_app_type] => utility
[patent_app_number] => 11/140618
[patent_app_country] => US
[patent_app_date] => 2005-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 24450
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20060025379.pdf
[firstpage_image] =>[orig_patent_app_number] => 11140618
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/140618 | Small molecule stimulators of neuronal growth | May 25, 2005 | Issued |
Array
(
[id] => 803440
[patent_doc_number] => 07423144
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-09
[patent_title] => 'Purine Derivatives as adenosine A1 receptor agonists and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/137632
[patent_app_country] => US
[patent_app_date] => 2005-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 44503
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/423/07423144.pdf
[firstpage_image] =>[orig_patent_app_number] => 11137632
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/137632 | Purine Derivatives as adenosine A1 receptor agonists and methods of use thereof | May 24, 2005 | Issued |
Array
(
[id] => 7224350
[patent_doc_number] => 20050261241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses'
[patent_app_type] => utility
[patent_app_number] => 11/132317
[patent_app_country] => US
[patent_app_date] => 2005-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14021
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20050261241.pdf
[firstpage_image] =>[orig_patent_app_number] => 11132317
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/132317 | Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses | May 18, 2005 | Abandoned |
Array
(
[id] => 5028911
[patent_doc_number] => 20070270358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Cosmetic and/or Pharmaceutical Composition for the Treatment of the Rosacea'
[patent_app_type] => utility
[patent_app_number] => 11/569317
[patent_app_country] => US
[patent_app_date] => 2005-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3714
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270358.pdf
[firstpage_image] =>[orig_patent_app_number] => 11569317
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/569317 | Cosmetic and/or Pharmaceutical Composition for the Treatment of the Rosacea | May 17, 2005 | Abandoned |
Array
(
[id] => 7056426
[patent_doc_number] => 20050277601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Anticancer biangeloyl saponins'
[patent_app_type] => utility
[patent_app_number] => 11/131551
[patent_app_country] => US
[patent_app_date] => 2005-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 68
[patent_no_of_words] => 14455
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20050277601.pdf
[firstpage_image] =>[orig_patent_app_number] => 11131551
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/131551 | Anticancer biangeloyl saponins | May 16, 2005 | Issued |
Array
(
[id] => 263791
[patent_doc_number] => 07569556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-04
[patent_title] => 'Method of use of carboxylated polysaccharides topically on the eyeball'
[patent_app_type] => utility
[patent_app_number] => 11/125444
[patent_app_country] => US
[patent_app_date] => 2005-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 32
[patent_no_of_words] => 7058
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/569/07569556.pdf
[firstpage_image] =>[orig_patent_app_number] => 11125444
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/125444 | Method of use of carboxylated polysaccharides topically on the eyeball | May 9, 2005 | Issued |
Array
(
[id] => 7795879
[patent_doc_number] => 08124585
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-28
[patent_title] => 'Composition for relieving discomfort'
[patent_app_type] => utility
[patent_app_number] => 11/125201
[patent_app_country] => US
[patent_app_date] => 2005-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7725
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/124/08124585.pdf
[firstpage_image] =>[orig_patent_app_number] => 11125201
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/125201 | Composition for relieving discomfort | May 9, 2005 | Issued |
Array
(
[id] => 5662114
[patent_doc_number] => 20060252710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => '6-11 Bridged oxime erythromycin derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/122251
[patent_app_country] => US
[patent_app_date] => 2005-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16362
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252710.pdf
[firstpage_image] =>[orig_patent_app_number] => 11122251
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/122251 | 6-11 Bridged oxime erythromycin derivatives | May 3, 2005 | Abandoned |
Array
(
[id] => 7110546
[patent_doc_number] => 20050208001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'PPAR receptor activator compounds for treating cutaneous disorders/afflictions'
[patent_app_type] => utility
[patent_app_number] => 11/121124
[patent_app_country] => US
[patent_app_date] => 2005-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3210
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208001.pdf
[firstpage_image] =>[orig_patent_app_number] => 11121124
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/121124 | PPAR receptor activator compounds for treating cutaneous disorders/afflictions | May 3, 2005 | Abandoned |
Array
(
[id] => 7070085
[patent_doc_number] => 20050245470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Anticancer biangeloyl saponins'
[patent_app_type] => utility
[patent_app_number] => 11/117745
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 66
[patent_no_of_words] => 12429
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 44
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20050245470.pdf
[firstpage_image] =>[orig_patent_app_number] => 11117745
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/117745 | Anticancer biangeloyl saponins | Apr 26, 2005 | Issued |
Array
(
[id] => 24474
[patent_doc_number] => 07795467
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-09-14
[patent_title] => 'Bioabsorbable, biobeneficial polyurethanes for use in medical devices'
[patent_app_type] => utility
[patent_app_number] => 11/115699
[patent_app_country] => US
[patent_app_date] => 2005-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15889
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/795/07795467.pdf
[firstpage_image] =>[orig_patent_app_number] => 11115699
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/115699 | Bioabsorbable, biobeneficial polyurethanes for use in medical devices | Apr 25, 2005 | Issued |
Array
(
[id] => 7056424
[patent_doc_number] => 20050277599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Pentose derivatives as anti-hyperglycemic drugs'
[patent_app_type] => utility
[patent_app_number] => 11/109907
[patent_app_country] => US
[patent_app_date] => 2005-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 16757
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20050277599.pdf
[firstpage_image] =>[orig_patent_app_number] => 11109907
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/109907 | Pentose derivatives as anti-hyperglycemic drugs | Apr 18, 2005 | Issued |
Array
(
[id] => 7187901
[patent_doc_number] => 20050192250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds'
[patent_app_type] => utility
[patent_app_number] => 11/107662
[patent_app_country] => US
[patent_app_date] => 2005-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9369
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11107662
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/107662 | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds | Apr 13, 2005 | Abandoned |
Array
(
[id] => 7235425
[patent_doc_number] => 20050256300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Method for using a static electric field to induce crystallization and to control crystal form'
[patent_app_type] => utility
[patent_app_number] => 11/104714
[patent_app_country] => US
[patent_app_date] => 2005-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6599
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256300.pdf
[firstpage_image] =>[orig_patent_app_number] => 11104714
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/104714 | Method for using a static electric field to induce crystallization and to control crystal form | Apr 12, 2005 | Issued |
Array
(
[id] => 5858017
[patent_doc_number] => 20060228403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Nutritional supplements for cardiovascular health'
[patent_app_type] => utility
[patent_app_number] => 11/104123
[patent_app_country] => US
[patent_app_date] => 2005-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3383
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20060228403.pdf
[firstpage_image] =>[orig_patent_app_number] => 11104123
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/104123 | Nutritional supplements for cardiovascular health | Apr 11, 2005 | Abandoned |
Array
(
[id] => 6926487
[patent_doc_number] => 20050239743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Compositions and methods to inhibit restenosis'
[patent_app_type] => utility
[patent_app_number] => 11/103310
[patent_app_country] => US
[patent_app_date] => 2005-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5181
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239743.pdf
[firstpage_image] =>[orig_patent_app_number] => 11103310
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/103310 | Compositions and methods to inhibit restenosis | Apr 10, 2005 | Abandoned |
Array
(
[id] => 6952835
[patent_doc_number] => 20050227930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Cholesterol lowering combination'
[patent_app_type] => utility
[patent_app_number] => 11/102278
[patent_app_country] => US
[patent_app_date] => 2005-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2245
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20050227930.pdf
[firstpage_image] =>[orig_patent_app_number] => 11102278
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/102278 | Cholesterol lowering combination | Apr 7, 2005 | Abandoned |